Publication output of RANZCR radiation oncologists in 2022–23
Journal of Medical Imaging and Radiation Oncology · 2025
DOI: 10.1111/1754-9485.13807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2025. Verfasst von Daniel Roos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Radiation Oncologists, Radiation Oncology, Bibliometrics, Publishing. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
The purpose of this work was to determine the current publication output of Royal Australian and New Zealand College of Radiologists radiation oncologists (ROs) to serve as a baseline contributing to future assessment of the effectiveness of the College's Research Action Plan 2024–26.
Methods
An online survey was sent to all ROs in the College's member database in March–April 2024 requesting a list of publications between 2022 and 2023. A PubMed search was performed to cross‐check the self‐reported publications. Given the low response rate (8%), an additional PubMed search was performed for the non‐responders. The primary outcomes were publication proportions and rates, and the secondary outcomes were demographic correlates (gender, country, seniority).
Results
There were 536 eligible ROs (56% males; 80% practicing in Australia; median 12.4 years post‐Fellowship) with 1,012 unique publications identified. The proportions of ROs with at least one publication in any‐, first‐ and last‐author positions averaged 45%, 15% and 17% per year, respectively. On multivariable analysis, there were statistically significant differences in publications by seniority (higher proportions of last‐authorships but lower proportions of first‐authorships, for those ≥5 years post‐Fellowship) and by country (lower any‐, and last‐authorships for New Zealand [NZ] than Australia or Singapore). The mean numbers of any‐, first‐ and last‐authorships were 1.6, 0.18 and 0.29 per RO per year, respectively. On multivariable analysis, there were statistically significant differences by gender (males had more any‐, and first‐authorships), seniority (senior ROs had more last‐authorships but less first‐authorships) and country (lower numbers of any‐, and last‐authorships for New Zealand).
Conclusion
This organization‐wide study provides comprehensive baseline RO publication data and identifies opportunities for the College to further address correlated disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- School of Medicine, Adelaide University, Adelaide, South Australia, Australia.
- Member Engagement and Services Unit, Royal Australian and New Zealand College of Radiologists, Sydney, New South Wales, Australia.
- Alfred Health Radiation Oncology, Melbourne, Victoria, Australia.
- Department of Radiation Oncology, Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia.
- Alfred Health Radiation Oncology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Daniel Roos, Lisa Milner, Wee Loon Ong
Zitieren
APA
Roos, D., Milner, L., Kang, T., Quinn, E., & Ong, W. L. (2025). Publication output of RANZCR radiation oncologists in 2022–23. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13807
Vancouver
Roos D, Milner L, Kang T, Quinn E, Ong WL. Publication output of RANZCR radiation oncologists in 2022–23. Journal of Medical Imaging and Radiation Oncology. 2025. doi:10.1111/1754-9485.13807
BibTeX
@article{Roos2025,
author = {Roos, Daniel and Milner, Lisa and Kang, Therese and Quinn, Emma and Ong, Wee Loon},
title = {Publication output of RANZCR radiation oncologists in 2022–23},
journal = {Journal of Medical Imaging and Radiation Oncology},
year = {2025},
doi = {10.1111/1754-9485.13807}
}
EUVIMED